Charles Schwab’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $87.4M | Sell |
3,553,213
-24,637
| -0.7% | -$570K | 0.01% | 868 |
|
|
2026
Q1 | $85.6M | Buy |
3,577,850
+37,122
| +1% | +$907K | 0.01% | 809 |
|
|
2025
Q4 | $80.1M | Sell |
3,540,728
-378,411
| -10% | -$8.24M | 0.01% | 843 |
|
|
2025
Q3 | $78.9M | Sell |
3,919,139
-359,507
| -8% | -$6.02M | 0.01% | 846 |
|
|
2025
Q2 | $61.1M | Sell |
4,278,646
-192,952
| -4% | -$2.26M | 0.01% | 972 |
|
|
2025
Q1 | $47M | Sell |
4,471,598
-216,012
| -5% | -$2.44M | 0.01% | 1112 |
|
|
2024
Q4 | $56.8M | Buy |
4,687,610
+162,994
| +4% | +$2.13M | 0.01% | 1040 |
|
|
2024
Q3 | $66.5M | Sell |
4,524,616
-160,443
| -3% | -$2.24M | 0.01% | 907 |
|
|
2024
Q2 | $67.6M | Sell |
4,685,059
-23,619
| -0.5% | -$377K | 0.01% | 844 |
|
|
2024
Q1 | $76.7M | Sell |
4,708,678
-24,194
| -0.5% | -$378K | 0.02% | 748 |
|
|
2023
Q4 | $70.5M | Buy |
4,732,872
+21,692
| +0.5% | +$246K | 0.02% | 748 |
|
|
2023
Q3 | $53M | Buy |
4,711,180
+814,668
| +21% | +$9.46M | 0.02% | 836 |
|
|
2023
Q2 | $39.2M | Buy |
3,896,512
+418,818
| +12% | +$3.89M | 0.01% | 1027 |
|
|
2023
Q1 | $32.7M | Buy |
3,477,694
+83,558
| +2% | +$986K | 0.01% | 1126 |
|
|
2022
Q4 | $41.5M | Buy |
3,394,136
+265,128
| +8% | +$3.3M | 0.01% | 942 |
|
|
2022
Q3 | $38.8M | Sell |
3,129,008
-62,841
| -2% | -$1.1M | 0.01% | 921 |
|
|
2022
Q2 | $62.7M | Buy |
3,191,849
+230,423
| +8% | +$5.45M | 0.02% | 639 |
|
|
2022
Q1 | $77.3M | Buy |
2,961,426
+178,162
| +6% | +$4.74M | 0.02% | 626 |
|
|
2021
Q4 | $79M | Buy |
2,783,264
+78,432
| +3% | +$2.44M | 0.02% | 640 |
|
|
2021
Q3 | $86.3M | Buy |
2,704,832
+92,110
| +4% | +$3.09M | 0.03% | 561 |
|
|
2021
Q2 | $90.6M | Buy |
2,612,722
+37,729
| +1% | +$1.24M | 0.03% | 539 |
|
|
2021
Q1 | $75.8M | Buy |
2,574,993
+20,652
| +0.8% | +$635K | 0.03% | 599 |
|
|
2020
Q4 | $78.3M | Buy |
2,554,341
+764,894
| +43% | +$23.3M | 0.03% | 528 |
|
|
2020
Q3 | $50M | Buy |
1,789,447
+529,513
| +42% | +$13.4M | 0.02% | 668 |
|
|
2020
Q2 | $27M | Buy |
1,259,934
+145,039
| +13% | +$3.2M | 0.01% | 968 |
|
|
2020
Q1 | $25M | Buy |
1,114,895
+327,065
| +42% | +$8.96M | 0.01% | 863 |
|
|
2019
Q4 | $23.2M | Sell |
787,830
-269,669
| -26% | -$7.33M | 0.01% | 1104 |
|
|
2019
Q3 | $28.1M | Sell |
1,057,499
-90,678
| -8% | -$2.72M | 0.02% | 931 |
|
|
2019
Q2 | $38.8M | Buy |
1,148,177
+21,820
| +2% | +$708K | 0.02% | 708 |
|
|
2019
Q1 | $36.1M | Buy |
1,126,357
+1,003,362
| +816% | +$30.9M | 0.02% | 730 |
|
|
2018
Q4 | $3.88M | Buy |
+122,995
| New | +$4.03M | ﹤0.01% | 2032 |
|
Other funds holding ELAN
Charles Schwab's ELAN Position: Q2 2026 in Review
Charles Schwab reduced its Elanco Animal Health (ELAN) stake by 0.69% in Q2 2026, selling an estimated $570K and leaving 3,553,213 shares worth $87.4M. The position accounts for 0.01% of the portfolio, ranked #868.
Charles Schwab first reported a position in ELAN in Q4 2018 and has held it in 31 quarters since. The position peaked at $90.6M in Q2 2021. 518 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.
- Charles Schwab held 3,553,213 shares of Elanco Animal Health worth $87.4M as of Q2 2026.
- Charles Schwab sold 24,637 Elanco Animal Health shares in Q2 2026, an estimated $570K.
- Elanco Animal Health made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #868 holding.
- Charles Schwab first reported a position in Elanco Animal Health in Q4 2018 and has held it in 31 quarters since.
- Charles Schwab's Elanco Animal Health position peaked at $90.6M in Q2 2021.
- 518 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.